← The Wire
KROSNasdaq
Keros Therapeutics, Inc.
Pharmaceutical Preparations · CIK 1664710
Developing novel therapeutics for disorders linked to dysfunctional TGF-ß signaling pathways
red 8-K · 90d
$201M
Market cap
$10.93
Last close
-0.6%
1D
-0.5%
5D
353K
Volume
Price · last 39 sessions-6.7%
May 4L $9.91 · H $12.07Jun 29
209
Total filings
Jun 25, 2026
Last filing
12/31
Fiscal year end
8-KExecutive Change · Reg FD DisclosureJun 25, 20268-KShareholder VoteJun 3, 20268-KReg FD DisclosureJun 1, 202610-Q10-QMay 14, 20268-KResults of OperationsMay 14, 2026DEFA14ADEFA14AApr 22, 2026DEF 14ADEF 14AApr 22, 20268-KCompany UpdateMar 9, 20268-KReg FD DisclosureMar 4, 202610-K10-KMar 4, 20268-KResults of OperationsMar 4, 20268-KExecutive Change · Reg FD DisclosureFeb 26, 20268-KReg FD DisclosureFeb 18, 20268-KReg FD DisclosureJan 9, 202610-Q10-QNov 5, 20258-KResults of OperationsNov 5, 20258-KExecutive Change · Material AgreementOct 15, 20258-KCompany UpdateSep 8, 20258-KReg FD DisclosureAug 28, 20258-KCompany UpdateAug 20, 20258-KExecutive Change · Reg FD DisclosureAug 6, 202510-Q10-QAug 6, 20258-KResults of OperationsAug 6, 20258-KCompany UpdateJul 17, 20258-KExecutive ChangeJul 15, 20258-KShareholder Vote · Company UpdateJun 9, 20258-KReg FD DisclosureJun 6, 20258-KExit / Disposal Costs · Company UpdateMay 29, 2025DEFA14ADEFA14AMay 27, 2025DEFA14ADEFA14AMay 19, 2025DEFA14ADEFA14AMay 19, 2025DEFA14ADEFA14AMay 19, 20258-KReg FD DisclosureMay 12, 2025DEFA14ADEFA14AMay 9, 202510-Q10-QMay 6, 20258-KResults of OperationsMay 6, 2025DEFA14ADEFA14AApr 23, 2025DEF 14ADEF 14AApr 23, 20258-KMaterial AgreementApr 18, 20258-KMaterial Agreement · Security-Holder RightsApr 10, 20258-KCompany UpdateMar 31, 20258-KBylaw AmendmentMar 6, 20258-KReg FD DisclosureFeb 28, 202510-K10-KFeb 26, 20258-KResults of OperationsFeb 26, 20258-KReg FD DisclosureJan 30, 20258-KCompany UpdateJan 21, 20258-KCompany UpdateJan 15, 20258-KReg FD DisclosureJan 10, 20258-KCompany UpdateDec 12, 20248-KCompany UpdateDec 10, 20248-KMaterial Agreement · Company UpdateDec 3, 20248-KReg FD DisclosureNov 26, 202410-Q10-QNov 6, 20248-KResults of OperationsNov 6, 20248-KReg FD DisclosureNov 6, 20248-KExecutive Change · Company UpdateOct 16, 20248-KCompany UpdateSep 30, 20248-KCompany UpdateSep 3, 20248-KReg FD DisclosureAug 28, 20248-KReg FD DisclosureAug 7, 202410-Q10-QAug 7, 20248-KResults of OperationsAug 7, 20248-KCompany UpdateJun 17, 2024424B5424B5Jun 17, 20248-KExecutive Change · Company UpdateJun 17, 20248-KCompany UpdateJun 17, 20248-KCompany UpdateJun 4, 20248-KReg FD DisclosureJun 3, 20248-KShareholder VoteMay 30, 20248-KExecutive ChangeMay 28, 202410-Q10-QMay 8, 20248-KResults of OperationsMay 8, 2024DEFA14ADEFA14AApr 17, 2024DEF 14ADEF 14AApr 17, 20248-KCompany UpdateMar 14, 20248-KReg FD DisclosureMar 6, 20248-KReg FD DisclosureMar 5, 20248-KExecutive ChangeMar 5, 202410-K10-KFeb 28, 2024
Insider Activity
In the 90 days to Mar 9, 2026: 1 insider bought $22K · 4 sold $332K.
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| Mar 9, 2026 | Bienaime Jean JacquesDirector | Buy | 2,000 | $11.21 | $22K |
| Feb 19, 2026 | Seehra JasbirCHIEF EXECUTIVE OFFICER | Sell | 7,015 | $16.17 | $113K |
| Feb 18, 2026 | Cho EstherSVP, General Counsel | Sell | 4,745 | $16.35 | $78K |
| Feb 18, 2026 | Regnante KeithCHIEF FINANCIAL OFFICER | Sell | 4,739 | $16.35 | $77K |
| Feb 18, 2026 | Lerner Lorena RaquelChief Science Officer | Sell | 3,873 | $16.35 | $63K |
| Oct 15, 2025 | Schneeberger DanielTenPercentOwner | Sell | 4,391,237 | $17.75 | $77.9M |
| Oct 15, 2025 | Pontifax (China) Iv L.P.TenPercentOwner | Sell | 2,284,612 | $17.75 | $40.6M |
| Oct 15, 2025 | Pontifax (China) Iv L.P.TenPercentOwner | Sell | 1,226,412 | $17.75 | $21.8M |
| Oct 15, 2025 | Pontifax (China) Iv L.P.TenPercentOwner | Sell | 1,121,045 | $17.75 | $19.9M |
| Oct 15, 2025 | Schneeberger DanielTenPercentOwner | Sell | 743,358 | $17.75 | $13.2M |
| Oct 15, 2025 | Schneeberger DanielTenPercentOwner | Sell | 254,669 | $17.75 | $4.5M |
| Oct 15, 2025 | Pontifax (China) Iv L.P.TenPercentOwner | Sell | 155,262 | $17.75 | $2.8M |
Open-market buys & sells (Form 4, transaction codes P/S). Source: SEC structured insider data.
Similar companies
Comparable business profile · signals at a glance